Chuan-dong Zheng1, Su Min. 1. Department of Anesthesiology, Sun Yat-sen University Tungwah Hospital, Dongguan, Guangdong Province, 523110, China. zhcdong@126.com
Abstract
OBJECTIVE: To investigate the protective effect of Shenfu Injection (SFI) against myocardium ischemia/reperfusion injury (IRI) in mitral valve replacement (MVR) with cardiopulmonary bypass (CPB). METHODS:Forty patients undergoing selective MVR were randomly assigned to the control group and trial Groups I, II, III, and IV according to the different administrations of SFI, 8 patients in each group. The changes of systolic blood pressure (SBP), mean blood pressure (MBP), diastolic blood pressure (DBP) in each group were monitored, respectively. The recovering percentage of spontaneous heart beat, the heart rate (HR) and cardiac rhythm as well as the abnormal duration of ECG-ST segment were recorded after the restoration of heart beat. The serum concentration of cardiac troponin I (cTnI), malondialdehyde (MDA) and the activity of superoxide dismutase (SOD) were determined as well. RESULTS: (1) The SBP, MBP and DBP values, the recovering rate of spontaneous heart beat, HR, ECG-ST, atrioventricular block and ventricular arrhythmia were significantly improved in group IV compared with any other groups. (2) Compared with the control group, the postoperative serum contents of cTnI and MDA were significantly decreased, but the activity of SOD was significantly increased in group IV. CONCLUSIONS: SFI had a certain protective effect against myocardium IRI. Moreover, better efficacy was seen with the administration of 1.5 mL/kg SFI into CPB priming fluid and pumping 1.5 mL/kg SFI via CPB as soon as the clamped aorta was unclamped.
RCT Entities:
OBJECTIVE: To investigate the protective effect of Shenfu Injection (SFI) against myocardium ischemia/reperfusion injury (IRI) in mitral valve replacement (MVR) with cardiopulmonary bypass (CPB). METHODS: Forty patients undergoing selective MVR were randomly assigned to the control group and trial Groups I, II, III, and IV according to the different administrations of SFI, 8 patients in each group. The changes of systolic blood pressure (SBP), mean blood pressure (MBP), diastolic blood pressure (DBP) in each group were monitored, respectively. The recovering percentage of spontaneous heart beat, the heart rate (HR) and cardiac rhythm as well as the abnormal duration of ECG-ST segment were recorded after the restoration of heart beat. The serum concentration of cardiac troponin I (cTnI), malondialdehyde (MDA) and the activity of superoxide dismutase (SOD) were determined as well. RESULTS: (1) The SBP, MBP and DBP values, the recovering rate of spontaneous heart beat, HR, ECG-ST, atrioventricular block and ventricular arrhythmia were significantly improved in group IV compared with any other groups. (2) Compared with the control group, the postoperative serum contents of cTnI and MDA were significantly decreased, but the activity of SOD was significantly increased in group IV. CONCLUSIONS: SFI had a certain protective effect against myocardium IRI. Moreover, better efficacy was seen with the administration of 1.5 mL/kg SFI into CPB priming fluid and pumping 1.5 mL/kg SFI via CPB as soon as the clamped aorta was unclamped.
Authors: E Vermes; M Mesguich; R Houel; C Soustelle; P Le Besnerais; M L Hillion; D Loisance Journal: Ann Thorac Surg Date: 2000-12 Impact factor: 4.330
Authors: J Błaszczyk; J Kedziora; J Zasłonka; S Szram; L Pawlicki; E Sibińska; R Jaszewski; A Iwaszkiewicz; M Mussur Journal: Med Sci Monit Date: 2000 Sep-Oct
Authors: Ken Suzuki; Bari Murtuza; Ivan A Sammut; Najma Latif; Jay Jayakumar; Ryszard T Smolenski; Yasufumi Kaneda; Yoshiki Sawa; Hikaru Matsuda; Magdi H Yacoub Journal: Circulation Date: 2002-09-24 Impact factor: 29.690
Authors: D Bimmel; B Patermann; T Schlosser; K Winkler; K Tiemann; J A Likungu; C J Preusse; A Welz Journal: J Cardiovasc Surg (Torino) Date: 2003-04 Impact factor: 1.888
Authors: Yuqiao Zhang; Dali Tian; Yuyou Huang; Ling Li; Juan Mao; Juan Tian; Jinsong Ding Journal: Acta Pharm Sin B Date: 2016-06-11 Impact factor: 11.413
Authors: Jingyu Ni; Yang Shi; Lan Li; Jingrui Chen; Lingyan Li; Min Li; Jinqiang Zhu; Yan Zhu; Guanwei Fan Journal: Evid Based Complement Alternat Med Date: 2017-06-15 Impact factor: 2.629
Authors: Yu Hong Li; Bin Yu; Zhen Zhen Duan; Olunga Mary Akinyi; Jia Hui Yu; Kun Zhou; Yue Zhang; Xiu Mei Gao Journal: PLoS One Date: 2014-03-24 Impact factor: 3.240